Plectin 1 links intermediate filaments to costameric sarcolemma through beta-synemin, alpha-dystrobrevin and actin. 2008

Takao Hijikata, and Akio Nakamura, and Keitaro Isokawa, and Michihiro Imamura, and Katsutoshi Yuasa, and Ryoki Ishikawa, and Kazuhiro Kohama, and Shinichi Takeda, and Hiroshi Yorifuji
Department of Anatomy and Cell Biology, Faculty of Pharmacy, Research Institute of Pharmaceutical Sciences, Musashino University, Tokyo, Japan. hijikata@musashino-u.ac.jp

In skeletal muscles, the sarcolemma is possibly stabilized and protected against contraction-imposed stress by intermediate filaments (IFs) tethered to costameric sarcolemma. Although there is emerging evidence that plectin links IFs to costameres through dystrophin-glycoprotein complexes (DGC), the molecular organization from plectin to costameres still remains unclear. Here, we show that plectin 1, a plectin isoform expressed in skeletal muscle, can interact with beta-synemin, actin and a DGC component, alpha-dystrobrevin, in vitro. Ultrastructurally, beta-synemin molecules appear to be incorporated into costameric dense plaques, where they seem to serve as actin-associated proteins rather than IF proteins. In fact, they can bind actin and alpha-dystrobrevin in vitro. Moreover, in vivo immunoprecipitation analyses demonstrated that beta-synemin- and plectin-immune complexes from lysates of muscle light microsomes contained alpha-dystrobrevin, dystrophin, nonmuscle actin, metavinculin, plectin and beta-synemin. These findings suggest a model in which plectin 1 interacts with DGC and integrin complexes directly, or indirectly through nonmuscle actin and beta-synemin within costameres. The DGC and integrin complexes would cooperate to stabilize and fortify the sarcolemma by linking the basement membrane to IFs through plectin 1, beta-synemin and actin. Besides, the two complexes, together with plectin and IFs, might have their own functions as platforms for distinct signal transduction.

UI MeSH Term Description Entries
D007381 Intermediate Filament Proteins Filaments 7-11 nm in diameter found in the cytoplasm of all cells. Many specific proteins belong to this group, e.g., desmin, vimentin, prekeratin, decamin, skeletin, neurofilin, neurofilament protein, and glial fibrillary acid protein. Fibroblast Intermediate Filament Proteins,Filament Proteins, Intermediate,Proteins, Intermediate Filament
D007382 Intermediate Filaments Cytoplasmic filaments intermediate in diameter (about 10 nanometers) between the microfilaments and the microtubules. They may be composed of any of a number of different proteins and form a ring around the cell nucleus. Tonofilaments,Neurofilaments,Filament, Intermediate,Filaments, Intermediate,Intermediate Filament,Neurofilament,Tonofilament
D009137 Muscular Dystrophy, Animal MUSCULAR DYSTROPHY that occurs in VERTEBRATE animals. Animal Muscular Dystrophies,Animal Muscular Dystrophy,Dystrophies, Animal Muscular,Dystrophy, Animal Muscular,Muscular Dystrophies, Animal
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D000199 Actins Filamentous proteins that are the main constituent of the thin filaments of muscle fibers. The filaments (known also as filamentous or F-actin) can be dissociated into their globular subunits; each subunit is composed of a single polypeptide 375 amino acids long. This is known as globular or G-actin. In conjunction with MYOSINS, actin is responsible for the contraction and relaxation of muscle. F-Actin,G-Actin,Actin,Isoactin,N-Actin,alpha-Actin,alpha-Isoactin,beta-Actin,gamma-Actin,F Actin,G Actin,N Actin,alpha Actin,alpha Isoactin,beta Actin,gamma Actin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012508 Sarcolemma The excitable plasma membrane of a muscle cell. (Glick, Glossary of Biochemistry and Molecular Biology, 1990) Sarcolemmas
D016189 Dystrophin A muscle protein localized in surface membranes which is the product of the Duchenne/Becker muscular dystrophy gene. Individuals with Duchenne muscular dystrophy usually lack dystrophin completely while those with Becker muscular dystrophy have dystrophin of an altered size. It shares features with other cytoskeletal proteins such as SPECTRIN and alpha-actinin but the precise function of dystrophin is not clear. One possible role might be to preserve the integrity and alignment of the plasma membrane to the myofibrils during muscle contraction and relaxation. MW 400 kDa.
D049029 Dystrophin-Associated Proteins A group of proteins that associate with DYSTROPHIN at the CELL MEMBRANE to form the DYSTROPHIN-ASSOCIATED PROTEIN COMPLEX. Dystrophin Associated Proteins
D050505 Mutant Proteins Proteins produced from GENES that have acquired MUTATIONS. Mutant Protein,Protein, Mutant,Proteins, Mutant

Related Publications

Takao Hijikata, and Akio Nakamura, and Keitaro Isokawa, and Michihiro Imamura, and Katsutoshi Yuasa, and Ryoki Ishikawa, and Kazuhiro Kohama, and Shinichi Takeda, and Hiroshi Yorifuji
May 2002, Molecular biology of the cell,
Takao Hijikata, and Akio Nakamura, and Keitaro Isokawa, and Michihiro Imamura, and Katsutoshi Yuasa, and Ryoki Ishikawa, and Kazuhiro Kohama, and Shinichi Takeda, and Hiroshi Yorifuji
April 2012, Journal of dermatological science,
Takao Hijikata, and Akio Nakamura, and Keitaro Isokawa, and Michihiro Imamura, and Katsutoshi Yuasa, and Ryoki Ishikawa, and Kazuhiro Kohama, and Shinichi Takeda, and Hiroshi Yorifuji
August 1995, Biochemical and biophysical research communications,
Takao Hijikata, and Akio Nakamura, and Keitaro Isokawa, and Michihiro Imamura, and Katsutoshi Yuasa, and Ryoki Ishikawa, and Kazuhiro Kohama, and Shinichi Takeda, and Hiroshi Yorifuji
September 2000, The Journal of cell biology,
Takao Hijikata, and Akio Nakamura, and Keitaro Isokawa, and Michihiro Imamura, and Katsutoshi Yuasa, and Ryoki Ishikawa, and Kazuhiro Kohama, and Shinichi Takeda, and Hiroshi Yorifuji
February 1982, The Journal of cell biology,
Takao Hijikata, and Akio Nakamura, and Keitaro Isokawa, and Michihiro Imamura, and Katsutoshi Yuasa, and Ryoki Ishikawa, and Kazuhiro Kohama, and Shinichi Takeda, and Hiroshi Yorifuji
September 2006, Gut,
Takao Hijikata, and Akio Nakamura, and Keitaro Isokawa, and Michihiro Imamura, and Katsutoshi Yuasa, and Ryoki Ishikawa, and Kazuhiro Kohama, and Shinichi Takeda, and Hiroshi Yorifuji
October 1980, FEBS letters,
Takao Hijikata, and Akio Nakamura, and Keitaro Isokawa, and Michihiro Imamura, and Katsutoshi Yuasa, and Ryoki Ishikawa, and Kazuhiro Kohama, and Shinichi Takeda, and Hiroshi Yorifuji
June 2001, Journal of cell science,
Takao Hijikata, and Akio Nakamura, and Keitaro Isokawa, and Michihiro Imamura, and Katsutoshi Yuasa, and Ryoki Ishikawa, and Kazuhiro Kohama, and Shinichi Takeda, and Hiroshi Yorifuji
January 2008, Journal of cell science,
Takao Hijikata, and Akio Nakamura, and Keitaro Isokawa, and Michihiro Imamura, and Katsutoshi Yuasa, and Ryoki Ishikawa, and Kazuhiro Kohama, and Shinichi Takeda, and Hiroshi Yorifuji
February 2008, The Biochemical journal,
Copied contents to your clipboard!